Trinity Capital Inc. Provides $35 Million in Growth Capital to Monteris Medical to Support Neurosurgical Technology Advancements Accessibility Statement Skip NavigationPHOENIX, March 12, 2026 /PRNewswire/ -- Trinity Capital Inc.(Nasdaq: TRIN) (the "Company"), a leading international alternative asset manager, today announced the commitment of $35 million in growth capital to Monteris Medical("Monteris"), a MedTech company specializing in minimally invasive neurosurgical technology.Monteris Medical develops ...

When people say they’re looking for “dividend stocks,” many investors default to a handful of popular companies like Coca-Cola, Abbott Labs, PepsiCo, and Realty Income as the top suggestions. And I don’t blame them; I’ve written about all these companies before, and yes, they offer very attractive yields, packaged with consistency and reliability. However, these companies are considered safe, conservative choices. More News from Barchart Some investors might want to make their money work harder. And in ...

We started covering the 7.875% Notes Due 2029 ( TRINZ ) from Trinity Capital ( TRIN ) last year, when we assigned the debentures a 'Buy' rating. A lot has happened in the BDC space since, and todayWith an investment banking cash and derivatives trading background, Binary Tree Analytics ('BTA') aims to provide transparency and analytics in respect to capital markets instruments and trades. BTA focuses on CEFs, ETFs and Special Situations, and aims to deliver high annualized returns with a low volatility prof ...

Core Insights - Emboline, Inc. has secured $20 million in growth capital from Trinity Capital to support the commercialization of its Emboliner® Embolic Protection System, aimed at minimizing stroke risk during transcatheter aortic valve replacement (TAVR) procedures [1][1][1] Company Overview - Emboline, Inc. is a privately held medical technology company based in Santa Cruz, California, focused on developing technologies to reduce embolic complications during transcatheter cardiovascular procedures [1][1] - The company's lead product, the Emboliner® Embolic Protection System, is designed to provide full cerebral and systemic embolic protection by capturing and removing debris released during structural heart interventions [1][1] Funding and Development - The funding from Trinity Capital will support Emboline's upcoming commercial launch activities and the continued development of its embolic protection technology platform [1][1] - Emboline has completed enrollment in the PROTECT H2H investigational device exemption (IDE) clinical trial, which evaluates the Emboliner® system [1][1] Clinical and Regulatory Milestones - Results from the completed IDE clinical study will be presented at the American College of Cardiology Annual Scientific Session on March 29, 2026 [1][1] - The financing positions Emboline to prepare for a commercial launch in the United States and Europe later this year [1][1] Strategic Partnerships - Trinity Capital, an international alternative asset manager, has a history of deploying over $5.5 billion across more than 463 investments since its inception in 2008, indicating a strong partnership for Emboline [1][1]

Trinity Capital Inc. Provides $20 Million in Growth Capital to Emboline, Inc. to Advance Interventional Heart Procedure Technology Accessibility Statement Skip NavigationPHOENIX, March 11, 2026 /PRNewswire/ -- Trinity Capital Inc.(Nasdaq: TRIN) ("Trinity"), a leading international alternative asset manager, today announced the commitment of $20 million in growth capital to Emboline, Inc.("Emboline"), a MedTech company focused on reducing strokes and other complications during interventional heart procedures ...

Like other private credit companies in the industry, Trinity Capital ( TRIN ) has suffered selling pressure due to concerns about the performance of SaaS loans in the BDC sector. Trinity Capital, and other BDCs, originate loans toAnalyst’s Disclosure: I/we have a beneficial long position in the shares of TRIN, HTGC either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha ...

Group 1 - Trinity Capital Inc. (TRIN) is highlighted as one of the top three Business Development Companies (BDCs) alongside Kayne Anderson BDC, Inc. (KBDC) and Fidus Investment (FDUS) [1] Group 2 - Roberts Berzins has over a decade of experience in financial management, focusing on helping top-tier corporates with financial strategies and large-scale financings [2] - He has contributed to institutionalizing the REIT framework in Latvia to enhance the liquidity of pan-Baltic capital markets [2] - His policy-level work includes developing national SOE financing guidelines and frameworks for channeling private capital into affordable housing [2]

Group 1 - Business Development Companies (BDCs) have been facing challenges in recent quarters, with many high-quality options struggling to grow earnings [1] - Trinity Capital (TRIN) has emerged as an exception among BDCs, demonstrating resilience and potential for growth [1] - The investment strategy discussed involves a mix of classic dividend growth stocks, BDCs, REITs, and Closed-End Funds to enhance investment income while achieving total returns comparable to traditional index funds like the S&P [1]

Core Insights - Business Development Companies (BDCs) have been facing challenges in earnings growth over recent quarters, but Trinity Capital (TRIN) stands out as a notable exception [1] Industry Overview - The BDC sector has struggled with headwinds, impacting many high-quality options in terms of earnings growth [1] Company Analysis - Trinity Capital (TRIN) has demonstrated resilience and growth potential amidst the broader challenges faced by the BDC industry [1]

Core Insights - The equity market serves as a significant mechanism for wealth creation or destruction over the long term through daily price fluctuations [1] Group 1: Investment Focus - Pacifica Yield aims to create long-term wealth by focusing on undervalued high-growth companies, high-dividend stocks, REITs, and green energy firms [1]